Crawford Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $470K | Sell |
7,756
-726
| -9% | -$42.3K | 0.01% | 255 |
|
|
2025
Q4 | $458K | Buy |
8,482
+116
| +1% | +$5.58K | 0.01% | 259 |
|
|
2025
Q3 | $377K | Sell |
8,366
-379
| -4% | -$17.7K | 0.01% | 260 |
|
|
2025
Q2 | $405K | Sell |
8,745
-647
| -7% | -$31.8K | 0.01% | 251 |
|
|
2025
Q1 | $573K | Buy |
9,392
+917
| +11% | +$53.5K | 0.01% | 233 |
|
|
2024
Q4 | $479K | Buy |
8,475
+2,239
| +36% | +$125K | 0.01% | 239 |
|
|
2024
Q3 | $323K | Buy |
6,236
+1
| +0% | +$47 | 0.01% | 257 |
|
|
2024
Q2 | $259K | Sell |
6,235
-3,513
| -36% | -$157K | ﹤0.01% | 256 |
|
|
2024
Q1 | $529K | Buy |
9,748
+425
| +5% | +$21.6K | 0.01% | 220 |
|
|
2023
Q4 | $478K | Sell |
9,323
-1,777
| -16% | -$93.3K | 0.01% | 224 |
|
|
2023
Q3 | $644K | Buy |
11,100
+203
| +2% | +$12.4K | 0.01% | 211 |
|
|
2023
Q2 | $697K | Sell |
10,897
-1,193
| -10% | -$80K | 0.01% | 205 |
|
|
2023
Q1 | $838K | Sell |
12,090
-406
| -3% | -$28.6K | 0.02% | 197 |
|
|
2022
Q4 | $899K | Sell |
12,496
-550
| -4% | -$41.5K | 0.02% | 195 |
|
|
2022
Q3 | $927K | Buy |
13,046
+66
| +0.5% | +$4.79K | 0.02% | 188 |
|
|
2022
Q2 | $999K | Sell |
12,980
-1,014
| -7% | -$77.2K | 0.02% | 193 |
|
|
2022
Q1 | $1.02M | Buy |
13,994
+651
| +5% | +$43.7K | 0.02% | 200 |
|
|
2021
Q4 | $832K | Sell |
13,343
-1,066
| -7% | -$62.5K | 0.02% | 203 |
|
|
2021
Q3 | $853K | Buy |
14,409
+143
| +1% | +$9.42K | 0.02% | 199 |
|
|
2021
Q2 | $953K | Buy |
14,266
+65
| +0.5% | +$4.24K | 0.02% | 197 |
|
|
2021
Q1 | $897K | Sell |
14,201
-1,508
| -10% | -$93.8K | 0.02% | 188 |
|
|
2020
Q4 | $974K | Buy |
15,709
+308
| +2% | +$18.9K | 0.02% | 181 |
|
|
2020
Q3 | $929K | Sell |
15,401
-717
| -4% | -$43.2K | 0.03% | 179 |
|
|
2020
Q2 | $948K | Sell |
16,118
-168
| -1% | -$10K | 0.03% | 173 |
|
|
2020
Q1 | $908K | Sell |
16,286
-58
| -0.4% | -$3.54K | 0.03% | 170 |
|
|
2019
Q4 | $1.05M | Buy |
16,344
+335
| +2% | +$19.2K | 0.03% | 180 |
|
|
2019
Q3 | $812K | Buy |
16,009
+100
| +0.6% | +$4.7K | 0.02% | 190 |
|
|
2019
Q2 | $721K | Buy |
15,909
+1,170
| +8% | +$54.5K | 0.02% | 187 |
|
|
2019
Q1 | $703K | Sell |
14,739
-300
| -2% | -$14.9K | 0.02% | 186 |
|
|
2018
Q4 | $782K | Buy |
15,039
+439
| +3% | +$23.6K | 0.03% | 173 |
|
|
2018
Q3 | $906K | Hold |
14,600
| – | – | 0.03% | 172 |
|
|
2018
Q2 | $808K | Sell |
14,600
-293
| -2% | -$15.8K | 0.03% | 173 |
|
|
2018
Q1 | $942K | Sell |
14,893
-2,801
| -16% | -$180K | 0.03% | 167 |
|
|
2017
Q4 | $1.08M | Sell |
17,694
-2,300
| -12% | -$144K | 0.03% | 162 |
|
|
2017
Q3 | $1.27M | Buy |
19,994
+2,033
| +11% | +$119K | 0.04% | 150 |
|
|
2017
Q2 | $1M | Sell |
17,961
-1,520
| -8% | -$82.7K | 0.03% | 157 |
|
|
2017
Q1 | $1.06M | Buy |
19,481
+1,705
| +10% | +$93.5K | 0.04% | 156 |
|
|
2016
Q4 | $1.04M | Sell |
17,776
-4,489
| -20% | -$245K | 0.04% | 161 |
|
|
2016
Q3 | $1.2M | Sell |
22,265
-1,045
| -4% | -$67.1K | 0.04% | 162 |
|
|
2016
Q2 | $1.71M | Sell |
23,310
-518
| -2% | -$36.6K | 0.07% | 114 |
|
|
2016
Q1 | $1.52M | Sell |
23,828
-524
| -2% | -$33K | 0.06% | 123 |
|
|
2015
Q4 | $1.68M | Sell |
24,352
-281
| -1% | -$18.6K | 0.07% | 110 |
|
|
2015
Q3 | $1.46M | Buy |
24,633
+3,049
| +14% | +$193K | 0.06% | 122 |
|
|
2015
Q2 | $1.44M | Sell |
21,584
-10,651
| -33% | -$702K | 0.05% | 129 |
|
|
2015
Q1 | $2.08M | Buy |
32,235
+3,683
| +13% | +$231K | 0.08% | 103 |
|
|
2014
Q4 | $1.69M | Hold |
28,552
| – | – | 0.06% | 109 |
|
|
2014
Q3 | $1.46M | Buy |
28,552
+459
| +2% | +$22.9K | 0.05% | 109 |
|
|
2014
Q2 | $1.36M | Buy |
28,093
+16,938
| +152% | +$835K | 0.05% | 118 |
|
|
2014
Q1 | $580K | Buy |
11,155
+55
| +0.5% | +$2.93K | 0.02% | 168 |
|
|
2013
Q4 | $590K | Buy |
11,100
+1,000
| +10% | +$50.9K | 0.02% | 163 |
|
|
2013
Q3 | $467K | Buy |
10,100
+1,322
| +15% | +$58K | 0.02% | 173 |
|
|
2013
Q2 | $392K | Buy |
+8,778
| New | +$381K | 0.02% | 165 |
|
Other funds holding BMY
VCM
VPM
Crawford Investment Counsel's BMY Position: Q1 2026 in Review
Crawford Investment Counsel reduced its Bristol-Myers Squibb (BMY) stake by 8.6% in Q1 2026, selling an estimated $42.3K and leaving 7,756 shares worth $470K. The position accounts for 0.01% of the portfolio, ranked #255.
Crawford Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08M in Q1 2015. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Crawford Investment Counsel held 7,756 shares of Bristol-Myers Squibb worth $470K as of Q1 2026.
- Crawford Investment Counsel sold 726 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.3K.
- Bristol-Myers Squibb made up 0.01% of Crawford Investment Counsel's portfolio in Q1 2026, its #255 holding.
- Crawford Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Crawford Investment Counsel's Bristol-Myers Squibb position peaked at $2.08M in Q1 2015.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.